
BioGeneration Ventures (BGV) is a venture capital company focused on early-stage European biotech, medtech, and diagnostics companies. With a strong track record of significant financial returns, BGV invests in healthcare innovations and builds world-class teams. The company manages over €100 million, targeting areas where scientific innovation, unmet medical needs, and the potential for significant proof of concept converge. BGV collaborates with founding teams to mature science and build companies, using its expertise to guide progress into clinical trials, leading to successful drug development and value realization for its investors.